Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

Summary

RATIONALE: Abiraterone acetate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I/II trial is studying the side effects and best dose of abiraterone acetate and to see how well it works in treating postmenopausal women with advanced or metastatic breast cancer.

Timeline

Start

2008-10

Primary completion

2016-06-04

Completion

2016-06-04

Drugs

Indications